
TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 16
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.13898
DO  - doi:10.1111/ajt.13898
SP  - 405
EP  - 798
PY  - 2016
ER  - 

TY  - JOUR
AU  - de Andrea, Carlos E
AU  - Hogendoorn, Pancras CW
TI  - Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 226
IS  - 2
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.3003
DO  - doi:10.1002/path.3003
SP  - 219
EP  - 228
KW  - growth plate
KW  - osteochondroma
KW  - gradients
KW  - polarity
KW  - primary cilia
KW  - proteoglycans
KW  - bone tumour
PY  - 2012
AB  - Abstract Chondrocytes interact with their neighbours through their cartilaginous extracellular matrix (ECM). Chondrocyte?matrix interactions compensate the lack of cell?cell contact and are modulated by proteoglycans and other molecules. The epiphyseal growth plate is a highly organized tissue responsible for long bone elongation. The growth plate is regulated by gradients of morphogens that are established by proteoglycans. Morphogens diffuse across the ECM, creating short- and long-range signalling that lead to the formation of a polarized tissue. Mutations affecting genes that modulate cell?matrix interactions are linked to several human disorders. Homozygous mutations of EXT1/EXT2 result in reduced synthesis and shortened heparan sulphate chains on both cell surface and matrix proteoglycans. This disrupts the diffusion gradients of morphogens and signal transduction in the epiphyseal growth plate, contributing to loss of cell polarity and osteochondroma formation. Osteochondromas are cartilage-capped bony projections arising from the metaphyses of endochondral bones adjacent to the growth plate. The osteochondroma cap is formed by cells with homozygous mutation of EXT1/EXT2 and committed stem cells/wild-type chondrocytes. Osteochondroma serves as a niche (a permissive environment), which facilitates the committed stem cells/wild-type chondrocytes to acquire secondary genetic changes to form a secondary peripheral chondrosarcoma. In such a scenario, the micro-environment is the site of the initiating processes that ultimately lead to cancer. Copyright ? 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
ER  - 

AU  - Benton, Richard L.
AU  - Whittemore, Scott R.
C7  - pp. 99-125
TI  - Cellular Grafting Strategies to Enhance Regeneration in the Mammalian Spinal Cord
SN  - 9783527315048
UR  - https://doi.org/10.1002/9783527610365.ch4
DO  - doi:10.1002/9783527610365.ch4
SP  - 99-125
KW  - cellular grafting strategies
KW  - enhance regeneration in the mammalian spinal cord
KW  - CNS and peripheral nervous system (PNS) tissue
KW  - transplantation into the injured spinal cord
KW  - Schwann cell transplantation
KW  - adult/postnatal and fetal-derived CNS precursor/sustentacular cell transplant-mediated regeneration in the mammalian spinal cord
KW  - non-CNS/PNS cellular grafting to facilitate host axonal regeneration
PY  - 2012
AB  - Summary This chapter contains sections titled: Introduction CNS and Peripheral Nervous System (PNS) Tissue Transplantation Into the Injured Spinal Cord Engineered PNS Tissue and Schwann Cell Transplantation in the Injured Spinal Cord Adult/Postnatal and Fetal-Derived CNS Precursor/Sustentacular Cell Transplant-Mediated Regeneration in the Mammalian Spinal Cord Non-CNS/PNS Cellular Grafting to Facilitate Host Axonal Regeneration Summary and Perspective
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Thrombosis and Haemostasis
VL  - 3
IS  - s1
SN  - 9783527315048
UR  - https://doi.org/10.1111/j.1538-7836.2005.0300c.x
DO  - doi:10.1111/j.1538-7836.2005.0300c.x
SP  - P0001
EP  - P2386
PY  - 2005
ER  - 

TY  - JOUR
AU  - Weng, Bo
AU  - Diao, Jianglin
AU  - Xu, Qun
AU  - Liu, Yuqing
AU  - Li, Changming
AU  - Ding, Ailing
AU  - Chen, Jun
C7  - 1500059
TI  - Bio-Interface of Conducting Polymer-Based Materials for Neuroregeneration
JO  - Advanced Materials Interfaces
JA  - Adv. Mater. Interfaces
VL  - 2
IS  - 8
SN  - 9783527315048
UR  - https://doi.org/10.1002/admi.201500059
DO  - doi:10.1002/admi.201500059
SP  - 1500059
KW  - Neuroregeneration
KW  - Bio-Interface
KW  - Conducting Polymers
KW  - Biomaterials
PY  - 2015
AB  - Nerve system diseases like Parkinson's disease, Huntington's disease, Alzheimer's disease, etc. seriously affect thousands of patients' lives every year, making them suffer from pains and inconvenience. Recently, bio-interfaces between neural cells/tissues and polymer based biomaterials attracted worldwide attention due to the ability of polymer based biomaterials to serve as nerve conduits, drug carriers and neurites guidance platform in neuroregeneration. The role that bio-interface played and the way it interacted with neural tissues and cells have been thoroughly investigated by the researchers. In this paper we mainly focus on reviewing the bio-interface between nerve tissues/cells and advanced functional biocompatible polymers, such as conducting polymers and advanced carbon composite materials. These advanced polymers can provide combined interfacial stimulations including interfacial external neurotrophic factors (NTFs) delivery, electrical stimulation, surface guidance and molecules decoration to lesion cells and tissues to promote neuroregeneration in vitro and in vivo, and have contributed greatly to nerve diseases therapy. At the end of this review, the criteria of polymer based biomaterials utilized in neuroregeneration are summarized and the perspectives for future development of bio-interfaces are also discussed.
ER  - 

TY  - JOUR
TI  - ASBMR/ISCD Joint Symposium on Bone Densitometry Y2K to Y3K
JO  - Journal of Bone and Mineral Research
VL  - 14
IS  - S1
SN  - 9783527315048
UR  - https://doi.org/10.1111/jbmr.1999.14.s1.1
DO  - doi:10.1111/jbmr.1999.14.s1.1
SP  - 1
EP  - 1919
PY  - 1999
ER  - 

TY  - JOUR
TI  - ASBMR 22nd annual meeting
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 15
IS  - S1
SN  - 9783527315048
UR  - https://doi.org/10.1002/jbmr.5650150102
DO  - doi:10.1002/jbmr.5650150102
SP  - S1
EP  - S584
PY  - 2000
ER  - 

TY  - JOUR
TI  - Past, Present and Future Insights into the Understanding and Treatment of Osteoarthritis: Molecular and Mechanical Approaches
JO  - International Journal of Experimental Pathology
VL  - 90
IS  - 1
SN  - 9783527315048
UR  - https://doi.org/10.1111/j.1365-2613.2008.00612.x
DO  - doi:10.1111/j.1365-2613.2008.00612.x
SP  - A30
EP  - A84
PY  - 2009
ER  - 

TY  - JOUR
AU  - Lombard Ph.D., Julian H.
TI  - Abstracts for the 8th World Congress for Microcirculation August 15-19, 2007 Milwaukee, Wisconsin, USA
JO  - Microcirculation
JA  - Microcirculation
VL  - 14
IS  - 4‐5
SN  - 9783527315048
UR  - https://doi.org/10.1080/10739680701413573
DO  - doi:10.1080/10739680701413573
SP  - 439
EP  - 569
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
JA  - Allergy
VL  - 68
IS  - s97
SN  - 9783527315048
UR  - https://doi.org/10.1111/all.12250
DO  - doi:10.1111/all.12250
SP  - 189
EP  - 336
PY  - 2013
ER  - 

TY  - JOUR
TI  - E-Posters, EP7
JO  - BJOG: An International Journal of Obstetrics & Gynaecology
JA  - BJOG: Int J Obstet Gy
VL  - 121
IS  - s2
SN  - 9783527315048
UR  - https://doi.org/10.1111/1471-0528.12786
DO  - doi:10.1111/1471-0528.12786
SP  - 92
EP  - 148
PY  - 2014
ER  - 

TY  - JOUR
TI  - P01. Posters 1
JO  - Australasian Journal of Dermatology
VL  - 38
IS  - S2
SN  - 9783527315048
UR  - https://doi.org/10.1111/ajd.1997.38.s2.77
DO  - doi:10.1111/ajd.1997.38.s2.77
SP  - 77
EP  - 124
PY  - 1997
ER  - 

TY  - JOUR
TI  - Abstract Presentations from the AABB Annual Meeting Orlando, FL, October 22–25, 2016
JO  - Transfusion
JA  - Transfusion
VL  - 56
IS  - S4
SN  - 9783527315048
UR  - https://doi.org/10.1111/trf.13807
DO  - doi:10.1111/trf.13807
SP  - 3A
EP  - 262A
PY  - 2016
ER  - 

TY  - JOUR
TI  - 2018 International Conference on Biotechnology and Bioengineering (ICBB2018) 24–26 October 2018, Budapest, Hungary
JO  - Basic & Clinical Pharmacology & Toxicology
JA  - Basic Clin Pharmacol Toxicol
VL  - 124
IS  - S1
SN  - 9783527315048
UR  - https://doi.org/10.1111/bcpt.13165
DO  - doi:10.1111/bcpt.13165
SP  - 3
EP  - 43
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts 1090 - 1621
JO  - American Journal of Transplantation
VL  - 4
IS  - s8
SN  - 9783527315048
UR  - https://doi.org/10.1111/j.1600-6135.2004.0480c.x
DO  - doi:10.1111/j.1600-6135.2004.0480c.x
SP  - 457
EP  - 604
PY  - 2004
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 19
IS  - S3
SN  - 9783527315048
UR  - https://doi.org/10.1111/ajt.15405
DO  - doi:10.1111/ajt.15405
SP  - 310
EP  - 590
PY  - 2019
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 18
IS  - S1
SN  - 9783527315048
UR  - https://doi.org/10.1111/1751-2980.12518
DO  - doi:10.1111/1751-2980.12518
SP  - 15
EP  - 159
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts Poster
JO  - American Journal of Transplantation
VL  - 9
IS  - s2
SN  - 9783527315048
UR  - https://doi.org/10.1111/j.1600-6143.2009.02659.x
DO  - doi:10.1111/j.1600-6143.2009.02659.x
SP  - 384
EP  - 729
PY  - 2009
ER  - 

TY  - JOUR
AU  - Grek, Christina L.
AU  - Rhett, J. Matthew
AU  - Ghatnekar, Gautam S.
TI  - Cardiac to cancer: Connecting connexins to clinical opportunity
JO  - FEBS Letters
VL  - 588
IS  - 8
SN  - 9783527315048
UR  - https://doi.org/10.1016/j.febslet.2014.02.047
DO  - doi:10.1016/j.febslet.2014.02.047
SP  - 1349
EP  - 1364
KW  - Connexin43
KW  - Gap junction
KW  - ACT1 peptide
KW  - Wound healing
KW  - CNS
KW  - Cancer
KW  - Therapeutic
KW  - Purinergic
PY  - 2014
AB  - Gap junctions and their connexin components are indispensable in mediating the cellular coordination required for tissue and organ homeostasis. The critical nature of their existence mandates a connection to disease while at the same time offering therapeutic potential. Therapeutic intervention may be offered through the pharmacological and molecular disruption of the pathways involved in connexin biosynthesis, gap junction assembly, stabilization, or degradation. Chemical inhibitors aimed at closing connexin channels, peptide mimetics corresponding to short connexin sequences, and gene therapy approaches have been incredibly useful molecular tools in deciphering the complexities associated with connexin biology. Recently, therapeutic potential in targeting connexins has evolved from basic research in cell-based models to clinical opportunity in the form of human trials. Clinical promise is particularly evident with regards to targeting connexin43 in the context of wound healing. The following review is aimed at highlighting novel advances where the pharmacological manipulation of connexin biology has proven beneficial in animals or humans.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Nephrology
VL  - 15
IS  - s4
SN  - 9783527315048
UR  - https://doi.org/10.1111/j.1440-1797.2010.01377_1.x
DO  - doi:10.1111/j.1440-1797.2010.01377_1.x
SP  - 27
EP  - 94
PY  - 2010
ER  - 
